Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. (Q51413561)

5 April 2018

title

Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. (English)

1 reference

5 April 2018

3

Gerhard Opelz

1 reference

5 April 2018

Christian Morath

1

1 reference

5 April 2018

Jörg Beimler

2

1 reference

5 April 2018

Sabine Scherer

4

1 reference

5 April 2018

Jan Schmidt

5

1 reference

5 April 2018

Stephan Macher-Goeppinger

6

1 reference

5 April 2018

Katrin Klein

7

1 reference

5 April 2018

Claudia Sommerer

8

1 reference

5 April 2018

Vedat Schwenger

9

1 reference

5 April 2018

Martin Zeier

10

1 reference

5 April 2018

Caner Süsal

11

1 reference

5 April 2018

publication date

29 February 2012

1 reference

5 April 2018

published in

Transplant International

1 reference

5 April 2018

volume

25

1 reference

5 April 2018

page(s)

506-517

1 reference

5 April 2018

issue

5

1 reference

5 April 2018

Presensitization: the problem and its management

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Current approaches to the management of highly sensitized kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Positive cross-match living donor kidney transplantation: longer-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

An integrative approach for the transplantation of high-risk sensitized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Kinetic Aspects of the Removal of IgG and Inhibitors in Hemophiliacs Using Protein A Immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Plasma exchange and immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Desensitization in HLA-incompatible kidney recipients and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Luminex-based desensitization protocols: the University of Wisconsin initial experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01447.X

10.1111/J.1432-2277.2012.01447.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

22372718

1 reference

5 April 2018